Debt-to-equity of Hepion Pharmaceuticals, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Hepion Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • Hepion Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 77%, a 44% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Hepion Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 77% -61% -44% 30 Sep 2025
Q2 2025 172% +83% +94% 30 Jun 2025
Q1 2025 208% +141% +211% 31 Mar 2025
Q4 2024 192% +144% +297% 31 Dec 2024
Q3 2024 138% +106% +328% 30 Sep 2024
Q2 2024 89% +63% +253% 30 Jun 2024
Q1 2024 67% +44% +188% 31 Mar 2024
Q4 2023 48% +31% +175% 31 Dec 2023
Q3 2023 32% +17% +112% 30 Sep 2023
Q2 2023 25% +12% +95% 30 Jun 2023
Q1 2023 23% +14% +141% 31 Mar 2023
Q4 2022 18% +9% +115% 31 Dec 2022
Q3 2022 15% +6% +75% 30 Sep 2022
Q2 2022 13% +2% +18% 30 Jun 2022
Q1 2022 10% -5% -34% 31 Mar 2022
Q4 2021 8% -21% -72% 31 Dec 2021
Q3 2021 9% -27% -75% 30 Sep 2021
Q2 2021 11% -19% -63% 30 Jun 2021
Q1 2021 15% -14% -50% 31 Mar 2021
Q4 2020 29% -16% -36% 31 Dec 2020
Q3 2020 35% -31% -46% 30 Sep 2020
Q2 2020 30% -86% -74% 30 Jun 2020
Q1 2020 29% -501% -95% 31 Mar 2020
Q4 2019 45% -312% -87% 31 Dec 2019
Q3 2019 66% -238% -78% 30 Sep 2019
Q2 2019 116% -173% -60% 30 Jun 2019
Q1 2019 530% +375% +241% 31 Mar 2019
Q4 2018 357% +138% +63% 31 Dec 2018
Q3 2018 304% +95% +45% 30 Sep 2018
Q2 2018 289% -88% -23% 30 Jun 2018
Q1 2018 155% -1049% -87% 31 Mar 2018
Q4 2017 220% -495% -69% 31 Dec 2017
Q3 2017 209% -546% -72% 30 Sep 2017
Q2 2017 376% -59% -13% 30 Jun 2017
Q1 2017 1205% +998% +483% 31 Mar 2017
Q4 2016 714% +624% +695% 31 Dec 2016
Q3 2016 755% +711% +1623% 30 Sep 2016
Q2 2016 435% +413% +1932% 30 Jun 2016
Q1 2016 207% +154% +295% 31 Mar 2016
Q4 2015 90% +1481% 31 Dec 2015
Q3 2015 44% 30 Sep 2015
Q2 2015 21% 30 Jun 2015
Q1 2015 52% 31 Mar 2015
Q4 2014 -1391% 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.